Oral Wegovy (semaglutide 25 mg): the first approved oral GLP-1 for weight loss On December 22, 2025, the FDA approved oral Wegovy, making it the first and only oral GLP-1 medication approved specifically for weight management in adults
There's an exciting new IV fusion in town that I just had to try out
Anxiety and stress-related disorders DSIPs calming presence may extend a helping hand to those grappling with the clutches of anxiety and stress
In a 72-week study of adults without diabetes, average weight loss was 15.0% (34 lbs) for 5 mg, 19.5% (44 lbs) for 10 mg, 20.9% (48 lbs) for 15 mg, and 3.1% (7 lbs) for placebo
160 Amato et al
Meto requires baseline labs, assigns metabolic specialists, accepts insurance with typical $0$50 copays, and provides ongoing monitoring throughout treatment